Search Results
Aug 04, 2025, 08:30 ET Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas
sometimes fatal side effects, HyBryte has been well tolerated and shows no evidence of safety concerns to date. Its mechanism of action is not linked to DNA damage, a significant distinction that positions it as a potentially safer alternative in a treatment landscape where many options carry risks such as
More news about: NetworkNewsWire
Aug 04, 2025, 07:00 ET Harley-Davidson Appoints Artie Starrs as President and Chief Executive Officer
the United States. LiveWire is the future in the making for the pursuit of urban adventure and beyond. Drawing on its DNA as an agile disruptor from the lineage of Harley-Davidson and capitalizing on a decade of learnings in the EV sector, LiveWire's ambition is to be the
More news about: Harley-Davidson, Inc.
Aug 04, 2025, 06:05 ET THINK BOLD FESTIVAL LAUNCHES GLOBAL MUSIC DISTRIBUTION COMPANY, AMFM, TO BUILD MUSIC INDUSTRY INFRASTRUCTURE IN NORTHEAST FLORIDA
power to create on their terms while turning fans into loyal communities. We're building something that's global in reach but rooted in the cultural DNA of Northeast Florida." Building a Music Industry Hub in Northeast Florida
More news about: AMFM Entertainment
Aug 01, 2025, 13:18 ET BillionToOne Expands Executive Team to Support Growth of UNITY and Northstar Platforms
risk assessment for up to 14 recessive and X-linked genes, aneuploidies, and more all from a single maternal blood sample. Leveraging fetal cell-free DNA and proprietary Quantitative Counting Templates™ (QCT™) technology, UNITY supports early detection and personalized care to promote healthier pregnancy
More news about: BillionToOne
Aug 01, 2025, 10:45 ET ANNOUNCING: WHISKY LEGEND ANGELA D'ORAZIO NAMED CREATIVE DIRECTOR OF WHISKYMAKING AT COMPASS BOX
experienced judge at the world's leading competitions including IWSC, ISC, and the World Whiskies Awards. "Compass Box has innovation as part of its DNA, which means there's so much opportunity to let our curiosity and courage explore what more can be created through the art of blending," says D'Orazio,
More news about: Compass Box Scotch Whisky
Aug 01, 2025, 10:00 ET New Study Finds Hidden Disease in Nearly Half of Ovarian Cancer Patients in 'Remission'
and point to new drug combinations that could specifically target MRD. The research also explored the use of circulating tumor DNA (ctDNA)—fragments of cancer DNA in the blood stream—as a blood-based tool to detect MRD. The results were encouraging: ctDNA identified high-risk patients and offered
More news about: Break Through Cancer
Aug 01, 2025, 10:00 ET Mabwell Announces IND Application Acceptance for CDH17-Targeting ADC 7MW4911 from Both NMPA and FDA
off-target binding.Novel cleavable linker: Ensures precise payload release in tumor tissues.MF-6 payload: A proprietary DNA topoisomerase I inhibitor designed to overcome multidrug resistance (MDR), exhibiting superior plasma stability, controlled drug release, and potent
More news about: Mabwell
Aug 01, 2025, 08:51 ET APERTUM FOUNDATION A JOSIP HEIT VYHRÁVAJÚ VEĽKÝ SÚDNY SPOR O CENNÉ PAPIERE PROTI TEXASKÉMU REGULÁTOROVI
rozsahu. Chceli by sme vyjadriť uznanie Rade pre cenné papiere za to, že si uznali svoju chybu a zrušili príkaz." „Apertum Foundation od prvého dňa ponúka bezpečnú platformu, ktorá je v súlade s predpismi, ako aj špičkovú technológiu," povedal Josip Heit, hlavný poradca
More news about: Quinn Emanuel Urquhart & Sullivan, LLP
Aug 01, 2025, 07:00 ET MDA SPACE SELECTED BY ECHOSTAR FOR WORLD'S FIRST OPEN RAN D2D LEO CONSTELLATION
vision into an achievable mission – bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there. For
More news about: MDA Space
Jul 31, 2025, 16:05 ET Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025
IlluminaIllumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in
More news about: Illumina, Inc.
Jul 31, 2025, 12:37 ET D.Law Named Fastest Growing Law Firm by LABJ
individuals in a professional environment. "We cater to one person at a time," says Davtyan. "One employee, one attorney, one client. That's the DNA of our culture. We've always believed that if you focus on individuals—the right people, the right partners—everything else will follow." The
More news about: D.Law, Inc.
Jul 31, 2025, 12:02 ET ICONIC CONTEMPORARY ARTIST ED RUSCHA TO PARTNER WITH ASPEN ONE FOR 2025-26 ART IN UNEXPECTED PLACES PROGRAM
is the foundation for a meaningful and fulfilling life— originated in the 1940s and remains an integral part of both Aspen itself and the community's DNA. This has fueled the approach of Aspen Snowmass, and its parent company, Aspen One, to elevate art across its businesses, especially through the ArtUP
More news about: Aspen One
Jul 31, 2025, 11:21 ET Makera Steals the Spotlight at Open Sauce, Drawing Record Attention for Desktop Manufacturing Innovation
Reddit Group. From empowering hands-on creativity to supporting community-driven innovation, Makera's DNA is rooted in maker culture. Makera continues to lead the charge in accessible, high-precision desktop manufacturing. Learn more and join Makera's maker
More news about: Makera
Jul 31, 2025, 11:00 ET D'USSÉ® FRIDAY RETURNS THIS SUMMER IN COLLABORATION WITH LATTO, RAVYN LENAE, AND MORE TO SPARK A NATIONWIDE CELEBRATION OF CULTURE, WINS, AND COCKTAILS
bottle. The content will be amplified through various social and online video channels throughout the summer. "D'USSÉ has victory in its DNA. As the cognac crafted specifically for cocktails, it redefined the category from the moment it launched. Our Cellar Master, Agathe Boinot, is the youngest
More news about: D'USSÉ
Jul 31, 2025, 09:56 ET S4Capital's Monks Appoints Danny Lee as Managing Director for Greater China
our team and partners to build brands that shape culture, inspire action, and grow business - backed by Monks' global capabilities and digital-first DNA." Prior to joining Monks, Lee served as Chief Brand Officer at Bosideng, where he helped modernize one of
More news about: Monks
Jul 31, 2025, 09:30 ET Co-Diagnostics, Inc. Announces Second Quarter 2025 Earnings Release Date and Webcast
diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform and to identify
More news about: Co-Diagnostics
Jul 31, 2025, 09:25 ET Acurx Pharmaceuticals, Inc. Announces Reverse Stock Split
antibiotic candidates with a Gram-positive selective spectrum (GPSS®) that blocks the active site of the Gram+ specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that
More news about: Acurx Pharmaceuticals, Inc.
Jul 31, 2025, 09:00 ET Mars doubles down on pursuit of perfect peanut, investing $5M in pioneering agri-science
generations: mapping the peanut genome. As a co-founder of the Peanut Genome Initiative, Mars helped map more than 2.5 billion base pairs of DNA — roughly equivalent to the human genome — and has shared the data as open-source science available to the entire industry. This groundbreaking effort
More news about: Mars, Incorporated
Jul 31, 2025, 08:47 ET Weiser Books to Publish New Book by New York Times Bestselling Author Damien Echols
three teenagers, the West Memphis Three, convicted of a triple murder in 1994 despite the lack of physical evidence connecting them to the crime. New DNA evidence secured his release from death row in 2011. He has been featured in multiple books, documentaries, and podcasts. Echols spent his time on death
More news about: Red Wheel/Weiser LLC
Jul 31, 2025, 08:30 ET Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care
novel disease subtypes, protective genetic variants, and therapeutic targets. As part of this collaboration, GENEWIZ will apply its validated DNA sequencing technologies and expertise, to generate large-scale genomic data from biospecimens collected through Frenova's extensive nephrology research
More news about: Fresenius Medical Care Holdings, Inc.
Jul 31, 2025, 08:30 ET Actinium Presents Data Supporting Paradigm Changing Potential of ATNM-400 in Prostate Cancer Demonstrating Its Superior Efficacy and Improved Survival in Treatment Resistant Tumor Models versus Pluvicto and ARPI Therapy, and Also Enhanced Efficacy in Combination with ARPI Therapy at the 4th Annual Targeted Radiopharmaceuticals Summit
(ARPI) and Pluvicto® treatment. ATNM-400 leverages the alpha-particle emitter Ac-225, which can cause lethal irreversible double-stranded DNA breaks and is more potent compared to the beta-particle emitter Lutetium-177 (Lu-177) used by Pluvicto®, as well as a shorter path length
More news about: Actinium Pharmaceuticals, Inc.
Jul 31, 2025, 08:01 ET Ginkgo Bioworks Announces Date of Second Quarter 2025 Results Presentation
BOSTON, July 31, 2025 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A
More news about: Ginkgo Bioworks
Jul 31, 2025, 08:01 ET PAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025
subsidiary, Lucid Diagnostics (Nasdaq: LUCD), is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard® Esophageal DNA Test and EsoCheck® Esophageal Cell Collection Device—the first and only commercial tools for widespread early detection of esophageal precancer
More news about: PAVmed Inc.
Jul 30, 2025, 18:00 ET Trial Evaluating Blood Test for 10 Cancers Reaches Major Milestone
multi-cancer early detection research look for fragments of tumour-DNA circulating in blood, ENLIGHTEN measures coloured light signatures from proteins, molecules that can change even when cancers are too small to shed detectable DNA.
More news about: Proteotype Diagnostics
Jul 30, 2025, 18:00 ET Trial Evaluating Blood Test for 10 Cancers Reaches Major Milestone
multi-cancer early detection research look for fragments of tumour-DNA circulating in blood, ENLIGHTEN measures coloured light signatures from proteins, molecules that can change even when cancers are too small to shed detectable DNA.
More news about: Proteotype Diagnostics